出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年2月
Organ-on-chip market – Global Forecast to 2029
臓器チップ（OoC）市場 : 臓器の種類 (肝臓、腎臓、腸、肺、心臓)、製品 (機器、消耗品、ソフトウェア)、サービス (標準、カスタム)、モデルの種類、用途 (毒物学、創薬、幹細胞)、目的 – 2029年までの世界予測
Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose – Global Forecast to 2029
| ページ数 | 338 |
| 図表数 | 434 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The organ-on-chip market is expected to reach USD 631,073 thousand by 2029 from USD 123,285 thousand in 2024, at a CAGR of 38.6% during the forecast period.
臓器チップ（OoC）市場は、予測期間中に38.6％のCAGRで、2024年の123,285千米ドルから2029年までに631,073千米ドルに達すると予想されます。
The key factors driving the growth of the organ-on-chip market include growing awareness towards the development of alternative methods for animal model-based drug testing and increasing funding from government and private institutions for innovating in the organ-on-chip market. Developments in the field of bio fabrication and microfluidics also contribute to the growth of this market.
The organ-on-chip market has been segmented based on organ type, model type, product and service, application, purpose, and end-user.
“By model type, organ-based model segment accounted for the largest share of the organ-on-chip market”
Based on model type, the organ-on-chip market is categorized into organ-based model and disease-based models. In 2023, organ-based model accounted for the largest share of the market owing to factors such as greater accuracy offered by organ-based organ-on-chip models along with the growing ethical concerns regarding the use of animals for drug testing among other factors.
“By organ type, the liver-on-chip segment accounted for the largest share in the organ-on-chip market”
Based on organ type, the organ-on-chip market is segmented into liver, kidney, lung, heart, intestine and other organs. In 2023, the liver-on-chip segment accounted for a largest share of the organ-on-chip market. Growth in this market segment can be attributed to the significance of liver in drug metabolism and focus of pharmaceutical and biotechnology companies on developing new drugs which are tested for human hepatocytic toxicity on liver-on-chip models.
“North America: accounted for the largest share of the organ-on-chip market”
North America accounted for the largest share of the organ-on-chip market. The large share of the North America region can be attributed to increased government and private institution funding and increasing initiatives to grow awareness and promote adoption of this technology as a substitute to animal testing. Besides, the North America region has a well-established healthcare infrastructure which further supports the growth of this market. Also, presence of several market players in the region is another key factor supporting market growth. Some examples of these players include Emulate, Inc. (US), Obatala Sciences (US), SynVivo, Inc. (US), Nortis, Inc. (US) Axosim (US), among others.
“Europe: The second-largest region in the organ-on-chip market.”
The Europe organ-on-chip market is the second largest market for organ-on-chip. This is attributed to one of the major factors including the growing initiatives for advancements of organ-on-chip technologies, increasing use of advanced technologies such as artificial intelligence for drug development and testing. Collaboration and support offered by the government bodies and private institutions also aid in the growth of this market.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, Directors- 30%, and Executives – 25%
• By Country: North America- 40%, Europe- 30%, Asia Pacific- 20%, Latin America- 5%, and Middle East and Africa- 5%
Prominent Players
• Emulate, Inc. (US)
• MIMETAS B.V. (Netherlands)
• TissUse GmBH (Germany)
• Insphero (Switzerland)
• CN Bio Innovations Ltd (UK)
• Dynamic42 GmBH (Germany)
• React4Life (Italy)
• Biomimx S.R.L (Italy)
• Netri (France)
• SynVivo, Inc. (US)
• Nortis, Inc. (US)
• Axosim (US)
• Obatala Sciences (US)
• AlveoliX AG (Switzerland)
• Beonchip (Spain)
• Initio Cell (Netherlands)
• Netri SAS (France)
• Hesperos, Inc. (US)
• Lena Biosciences (US)
• RevivoCell (UK)
• Altis Biosystems (US)
• Bi/ond (Netherlands)
• Cherry Biotech (France)
• Fluigent (France)
• Elvesys (France)
Research Coverage:
This report provides a detailed picture of the organ-on-chip market. It aims at estimating the size and future growth potential of the market across different segments, such as the organ type, model type, product and service, application, purpose, end user and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the organ-on-chip market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provides insights on the following pointers
• Analysis of key drivers (development of alternative drug testing methods), opportunities (Development of multi-organ-chips and extended application in cosmetic and food industry), restraint (limited use of technology in preclinical phase) and challenges (low throughput and scalability) influencing the growth of the organ-on-chip market.
• Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the organ-on-chip market.
• Market Development: Comprehensive information about lucrative markets- the report analyses the organ-on-chip market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the organ-on-chip market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product and service offerings of leading players.
Table of Contents
1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 47
1.3 INCLUSIONS & EXCLUSIONS 47
1.4 MARKET SCOPE 48
FIGURE 1 ORGANS-ON-CHIPS MARKET SEGMENTATION 48
FIGURE 2 REGIONAL SEGMENTATION 48
1.4.1 YEARS CONSIDERED 49
1.4.2 CURRENCY CONSIDERED 49
1.5 RESEARCH LIMITATIONS 49
1.6 STAKEHOLDERS 50
1.7 SUMMARY OF CHANGES 50
1.7.1 RECESSION IMPACT 50
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
FIGURE 3 RESEARCH DESIGN 52
2.1.1 SECONDARY DATA 53
2.1.2 PRIMARY DATA 53
FIGURE 4 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 54
2.2 MARKET SIZE ESTIMATION 55
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023 55
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 56
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 57
2.2.1 MARKET SIZE ASSESSMENT AT SEGMENTAL LEVEL 57
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 57
2.3 MARKET GROWTH FORECAST 58
FIGURE 9 CAGR PROJECTIONS: ORGANS-ON-CHIPS MARKET, 2024–2029 59
FIGURE 10 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGANS-ON-CHIPS MARKET 60
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 60
FIGURE 11 DATA TRIANGULATION METHODOLOGY 61
2.5 STUDY ASSUMPTIONS 61
2.6 RISK ANALYSIS 62
2.7 RECESSION IMPACT ANALYSIS 62
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 62
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 63
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 63
3 EXECUTIVE SUMMARY 64
FIGURE 12 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2024 VS. 2029 (USD THOUSAND) 64
FIGURE 13 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2024 VS. 2029 (USD THOUSAND) 65
FIGURE 14 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD THOUSAND) 66
FIGURE 15 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2024 VS. 2029 (USD THOUSAND) 66
FIGURE 16 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND) 67
FIGURE 17 ORGANS-ON-CHIPS MARKET, BY END USER, 2024 VS. 2029 (USD THOUSAND) 68
FIGURE 18 GEOGRAPHICAL SNAPSHOT: ORGANS-ON-CHIPS MARKET 69
4 PREMIUM INSIGHTS 70
4.1 ORGANS-ON-CHIPS MARKET OVERVIEW 70
FIGURE 19 RISING ADOPTION OF ORGANS-ON-CHIPS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET 70
4.2 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SHARE, BY MODEL TYPE & COUNTRY (2023) 71
FIGURE 20 ORGAN-BASED MODELS TO DOMINATE NORTH AMERICAN ORGANS-ON-CHIPS MARKET IN 2023 71
4.3 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND) 71
FIGURE 21 TOXICOLOGY RESEARCH TO DOMINATE MARKET BY 2029 71
4.4 ORGANS-ON-CHIPS MARKET SHARE, BY END USER, 2023 72
FIGURE 22 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 72
4.5 ORGANS-ON-CHIPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 72
FIGURE 23 GERMANY TO REGISTER HIGHEST GROWTH RATE IN ORGANS-ON-CHIPS MARKET FROM 2024 TO 2029 72
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 74
FIGURE 24 ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 74
TABLE 4 ORGANS-ON-CHIPS MARKET: IMPACT ANALYSIS 75
5.2.1 DRIVERS 76
5.2.1.1 Increasing demand for animal-free testing 76
5.2.1.2 Ethical concerns regarding use of animal models in drug development 76
5.2.1.3 Growing drug discovery & development initiatives 77
5.2.1.4 Development of personalized medicines 77
5.2.1.5 Advancements in microfluidics and bioengineering 78
5.2.1.6 Increased government and private funding 78
5.2.1.7 Greater adoption of OOC technology by pharma & biotech companies 79
5.2.2 RESTRAINTS 80
5.2.2.1 Limitation of use restricted to preclinical trials 80
5.2.2.2 Limited scalability and throughput 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Development of human-on-a-chip models 81
5.2.3.2 Increasing applications in diverse industries 81
5.2.3.3 Developing hybrid business model providing both products and services 82
5.2.4 CHALLENGES 82
5.2.4.1 Lack of standardization 82
5.2.4.2 Mimicking complex tissues and organs 83
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR PRODUCT & SERVICE PROVIDERS 83
5.4 PRICING ANALYSIS 84
TABLE 5 AVERAGE SELLING PRICE FOR KEY PLAYERS, BY PRODUCT 84
5.5 VALUE CHAIN ANALYSIS 85
FIGURE 26 VALUE CHAIN ANALYSIS: RESEARCH & DEVELOPMENT PHASE ADDS MAXIMUM VALUE 85
5.6 ECOSYSTEM ANALYSIS 86
FIGURE 27 ECOSYSTEM ANALYSIS: ORGANS-ON-CHIPS MARKET 86
5.7 PATENT ANALYSIS 87
FIGURE 28 PATENT APPLICATIONS FOR ORGAN-ON-A-CHIP PRODUCTS, JANUARY 2012–DECEMBER 2023 87
TABLE 6 ORGANS-ON-CHIPS MARKET: INDICATIVE LIST OF PATENTS 87
5.8 SUPPLY CHAIN ANALYSIS 88
FIGURE 29 ORGANS-ON-CHIPS MARKET: SUPPLY CHAIN ANALYSIS 89
TABLE 7 OVERALL SUPPLY CHAIN ECOSYSTEM FOR ORGANS-ON-CHIPS MARKET 89
5.9 TECHNOLOGY ANALYSIS 90
5.10 CASE STUDY ANALYSIS 91
5.10.1 QUEEN MARY UNIVERSITY LONDON (QMUL) COLLABORATED WITH EMULATE TO ESTABLISH QUEEN MARY+EMULATE ORGANS-ON-CHIPS CENTRE 91
5.11 TRADE ANALYSIS 91
5.12 KEY CONFERENCES & EVENTS IN 2024 91
TABLE 8 ORGANS-ON-CHIPS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 91
5.13 REGULATORY ANALYSIS 93
5.13.1 REGULATORY ANALYSIS 93
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 12 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.14 PORTER’S FIVE FORCES ANALYSIS 96
TABLE 13 ORGANS-ON-CHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS 96
5.14.1 THREAT OF NEW ENTRANTS 96
5.14.2 THREAT OF SUBSTITUTES 96
5.14.3 BARGAINING POWER OF BUYERS 97
5.14.4 BARGAINING POWER OF SUPPLIERS 97
5.14.5 DEGREE OF COMPETITION 97
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 98
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PRODUCTS 98
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 98
6 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE 99
6.1 INTRODUCTION 100
TABLE 14 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 100
6.2 LIVER 100
6.2.1 INCREASING PRECLINICAL RESEARCH TO EVALUATE HEPATOTOXICITY TO AID MARKET GROWTH 100
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 101
TABLE 16 NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 101
TABLE 17 EUROPE: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 102
TABLE 18 ASIA PACIFIC: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 102
TABLE 19 LATIN AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 103
6.3 KIDNEY 103
6.3.1 USE OF KIDNEY-ON-A-CHIP MODELS FOR DIKI ASSESSMENT TO SUPPORT MARKET GROWTH 103
TABLE 20 KIDNEY-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 104
TABLE 21 NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 104
TABLE 22 EUROPE: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 105
TABLE 23 ASIA PACIFIC: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 105
TABLE 24 LATIN AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 106
6.4 INTESTINE 106
6.4.1 INCREASING RESEARCH ON GASTROINTESTINAL DISEASE TO PROMOTE GROWTH 106
TABLE 25 INTESTINE-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 107
TABLE 26 NORTH AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 107
TABLE 27 EUROPE: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 108
TABLE 28 ASIA PACIFIC: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 108
TABLE 29 LATIN AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 109
6.5 LUNG 109
6.5.1 ENHANCED PARTICLE SCREENING FOR EVALUATING PULMONARY TOXICITY TO SUPPORT ADOPTION 109
TABLE 30 LUNG-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 110
TABLE 31 NORTH AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 110
TABLE 32 EUROPE: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 111
TABLE 33 ASIA PACIFIC: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 111
TABLE 34 LATIN AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 112
6.6 HEART 112
6.6.1 INCREASING ADOPTION IN STUDYING CARDIOVASCULAR DISEASES TO DRIVE MARKET 112
TABLE 35 HEART-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 113
TABLE 36 NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 113
TABLE 37 EUROPE: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 114
TABLE 38 ASIA PACIFIC: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 114
TABLE 39 LATIN AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 115
6.7 OTHER ORGANS 115
TABLE 40 OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 115
TABLE 41 NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 115
TABLE 42 EUROPE: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 116
TABLE 43 ASIA PACIFIC: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 117
TABLE 44 LATIN AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 117
7 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE 118
7.1 INTRODUCTION 119
TABLE 45 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 119
7.2 ORGAN-BASED MODELS 119
7.2.1 INCREASING RESEARCH TO UNDERSTAND ORGAN PHYSIOLOGY TO SUPPORT MARKET GROWTH 119
TABLE 46 ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND) 120
TABLE 47 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 120
TABLE 48 EUROPE: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 121
TABLE 49 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 121
TABLE 50 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 122
7.3 DISEASE-BASED MODELS 122
7.3.1 GROWING USE OF OOC PLATFORMS FOR DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 122
TABLE 51 ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND) 123
TABLE 52 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 123
TABLE 53 EUROPE: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 124
TABLE 54 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 124
TABLE 55 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 125
8 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE 126
8.1 INTRODUCTION 127
TABLE 56 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 127
8.2 SERVICES 127
TABLE 57 ORGAN-ON-A-CHIP SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 127
TABLE 58 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 128
TABLE 59 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 128
TABLE 60 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 129
TABLE 61 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 129
TABLE 62 ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 130
8.2.1 CUSTOM SERVICES 130
8.2.1.1 Growing demand for customized platforms for therapeutics and research to aid growth 130
TABLE 63 CUSTOM SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 130
TABLE 64 NORTH AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 131
TABLE 65 EUROPE: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 131
TABLE 66 ASIA PACIFIC: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 132
TABLE 67 LATIN AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 132
8.2.2 STANDARD SERVICES 132
8.2.2.1 Increasing use of pre-seeded platforms for drug toxicity assessments to support growth 132
TABLE 68 STANDARD SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 133
TABLE 69 NORTH AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 133
TABLE 70 EUROPE: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 134
TABLE 71 ASIA PACIFIC: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 134
TABLE 72 LATIN AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 135
8.3 PRODUCTS 135
TABLE 73 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 135
TABLE 74 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 136
TABLE 75 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 136
TABLE 76 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 137
TABLE 77 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 137
TABLE 78 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 138
8.3.1 INSTRUMENTS 138
8.3.1.1 Increasing adoption of platforms for drug discovery and development to support market growth 138
TABLE 79 INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 139
TABLE 80 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 139
TABLE 81 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 140
TABLE 82 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 140
TABLE 83 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 141
8.3.2 CONSUMABLES & ACCESSORIES 141
8.3.2.1 Growing emphasis on using OOC models for research to drive market 141
TABLE 84 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 142
TABLE 85 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 142
TABLE 86 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 143
TABLE 87 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 143
TABLE 88 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 144
8.3.3 SOFTWARE 144
8.3.3.1 Increasing integration of AI for data analytics and prediction to support market growth 144
TABLE 89 SOFTWARE MARKET, BY REGION, 2022–2029 (USD THOUSAND) 144
TABLE 90 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 91 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 92 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 93 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 146
9 ORGANS-ON-CHIPS MARKET, BY APPLICATION 147
9.1 INTRODUCTION 148
TABLE 94 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 148
9.2 TOXICOLOGY RESEARCH 148
9.2.1 EFFECTIVE OUTCOMES TO SUPPORT GROWTH 148
TABLE 95 ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 149
TABLE 96 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 149
TABLE 97 EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 150
TABLE 98 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 150
TABLE 99 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 151
9.3 DRUG DISCOVERY 151
9.3.1 INCREASING FOCUS OF PHARMA COMPANIES ON ADOPTING OOC TO SUPPORT GROWTH 151
TABLE 100 ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION, 2022–2029 (USD THOUSAND) 152
TABLE 101 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 152
TABLE 102 EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 153
TABLE 103 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 153
TABLE 104 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 154
9.4 PHYSIOLOGICAL MODEL DEVELOPMENT 154
9.4.1 ACCURACY IN STUDYING IN VIVO MECHANISMS TO DRIVE MARKET 154
TABLE 105 ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2022–2029 (USD THOUSAND) 155
TABLE 106 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 155
TABLE 107 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 156
TABLE 108 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 156
TABLE 109 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 157
9.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 157
9.5.1 GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH 157
TABLE 110 ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD THOUSAND) 158
TABLE 111 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 158
TABLE 112 EUROPE: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 159
TABLE 113 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 159
TABLE 114 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 160
9.6 STEM CELL RESEARCH 160
9.6.1 GROWING FOCUS ON STEM CELL RESEARCH TO SUPPORT GROWTH 160
TABLE 115 ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 160
TABLE 116 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 161
TABLE 117 EUROPE: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 161
TABLE 118 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 162
TABLE 119 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 162
10 ORGANS-ON-CHIPS MARKET, BY PURPOSE 163
10.1 INTRODUCTION 164
TABLE 120 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 164
10.2 THERAPEUTICS 164
10.2.1 INCREASING USE OF OOC TECHNOLOGY IN PRECISION MEDICINE AND TARGETED THERAPY RESEARCH TO AID GROWTH 164
TABLE 121 ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY REGION, 2022–2029 (USD THOUSAND) 165
TABLE 122 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 165
TABLE 123 EUROPE: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 166
TABLE 124 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 166
TABLE 125 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 167
10.3 RESEARCH 167
10.3.1 INCREASING USE OF OOC PLATFORM FOR RESEARCH TO SUPPORT MARKET GROWTH 167
TABLE 126 ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 168
TABLE 127 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 168
TABLE 128 EUROPE: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 169
TABLE 129 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 169
TABLE 130 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 170
11 ORGANS-ON-CHIPS MARKET, BY END USER 171
11.1 INTRODUCTION 172
TABLE 131 ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 172
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 172
11.2.1 INCREASING COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES AND OOC MANUFACTURERS TO DRIVE MARKET 172
TABLE 132 ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD THOUSAND) 173
TABLE 133 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 173
TABLE 134 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 174
TABLE 135 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 174
TABLE 136 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 175
11.3 COSMETICS INDUSTRY 175
11.3.1 GROWING EMPHASIS ON ANIMAL-FREE DRUG TESTING TO PROMOTE MARKET GROWTH 175
TABLE 137 ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022–2029 (USD THOUSAND) 176
TABLE 138 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 176
TABLE 139 EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, 2022–2029 (USD THOUSAND) 177
TABLE 140 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 177
TABLE 141 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 178
11.4 ACADEMIC & RESEARCH INSTITUTES 178
11.4.1 INCREASING RESEARCH INTO APPLICATIONS OF OOC TECHNOLOGY TO SUPPORT MARKET GROWTH 178
TABLE 142 ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD THOUSAND) 179
TABLE 143 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 179
TABLE 144 EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 180
TABLE 145 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 180
TABLE 146 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 181
11.5 OTHER END USERS 181
TABLE 147 ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD THOUSAND) 182
TABLE 148 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 182
TABLE 149 EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, 2022–2029 (USD THOUSAND) 183
TABLE 150 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 183
TABLE 151 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 184
12 ORGANS-ON-CHIPS MARKET, BY REGION 185
12.1 INTRODUCTION 186
TABLE 152 ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 186
12.2 NORTH AMERICA 186
FIGURE 32 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT 187
TABLE 153 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 188
TABLE 154 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 188
TABLE 155 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 189
TABLE 156 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 189
TABLE 157 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 189
TABLE 158 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 190
TABLE 159 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 190
TABLE 160 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 191
TABLE 161 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 191
12.2.1 US 191
12.2.1.1 US to dominate market due to presence of major companies 191
TABLE 162 US: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 192
TABLE 163 US: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 192
TABLE 164 US: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 193
TABLE 165 US: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 193
TABLE 166 US: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 193
TABLE 167 US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 194
TABLE 168 US: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 194
TABLE 169 US: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 195
12.2.2 CANADA 195
12.2.2.1 Favorable regulatory environment to support market growth 195
TABLE 170 CANADA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 196
TABLE 171 CANADA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 196
TABLE 172 CANADA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 196
TABLE 173 CANADA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 197
TABLE 174 CANADA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 197
TABLE 175 CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 197
TABLE 176 CANADA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 198
TABLE 177 CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 198
12.2.3 NORTH AMERICA: RECESSION IMPACT 198
12.3 EUROPE 199
FIGURE 33 EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT 200
TABLE 178 EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 201
TABLE 179 EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 201
TABLE 180 EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 202
TABLE 181 EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 202
TABLE 182 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 202
TABLE 183 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 203
TABLE 184 EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 203
TABLE 185 EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 204
TABLE 186 EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 204
12.3.1 GERMANY 204
12.3.1.1 Favorable government policies to propel market 204
TABLE 187 GERMANY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 205
TABLE 188 GERMANY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 205
TABLE 189 GERMANY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 206
TABLE 190 GERMANY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 206
TABLE 191 GERMANY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 206
TABLE 192 GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 207
TABLE 193 GERMANY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 207
TABLE 194 GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 208
12.3.2 UK 208
12.3.2.1 Growing R&D expenditure in pharmaceutical industry to boost market 208
TABLE 195 UK: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 209
TABLE 196 UK: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 209
TABLE 197 UK: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 209
TABLE 198 UK: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 210
TABLE 199 UK: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 210
TABLE 200 UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 210
TABLE 201 UK: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 211
TABLE 202 UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 211
12.3.3 FRANCE 211
12.3.3.1 Growing funding for research projects to drive market 211
TABLE 203 FRANCE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 212
TABLE 204 FRANCE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 212
TABLE 205 FRANCE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 213
TABLE 206 FRANCE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 213
TABLE 207 FRANCE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 213
TABLE 208 FRANCE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 214
TABLE 209 FRANCE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 214
TABLE 210 FRANCE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 215
12.3.4 ITALY 215
12.3.4.1 Growing research to aid growth 215
TABLE 211 ITALY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 215
TABLE 212 ITALY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 216
TABLE 213 ITALY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 216
TABLE 214 ITALY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 216
TABLE 215 ITALY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 217
TABLE 216 ITALY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 217
TABLE 217 ITALY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 217
TABLE 218 ITALY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 218
12.3.5 SPAIN 218
12.3.5.1 Growing R&D expenditure to boost market 218
TABLE 219 SPAIN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 218
TABLE 220 SPAIN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 219
TABLE 221 SPAIN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 219
TABLE 222 SPAIN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 219
TABLE 223 SPAIN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 220
TABLE 224 SPAIN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 220
TABLE 225 SPAIN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 220
TABLE 226 SPAIN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 221
12.3.6 REST OF EUROPE 221
TABLE 227 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 222
TABLE 228 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 222
TABLE 229 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 222
TABLE 230 REST OF EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 223
TABLE 231 REST OF EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 223
TABLE 232 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 224
TABLE 233 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 224
TABLE 234 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 225
12.3.7 EUROPE: RECESSION IMPACT 225
12.4 ASIA PACIFIC 226
TABLE 235 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 226
TABLE 236 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 227
TABLE 237 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 227
TABLE 238 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 227
TABLE 239 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 228
TABLE 240 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 228
TABLE 241 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 228
TABLE 242 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 229
TABLE 243 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 229
12.4.1 CHINA 229
12.4.1.1 Increasing investments in scientific research and technology to drive market 229
TABLE 244 CHINA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 230
TABLE 245 CHINA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 230
TABLE 246 CHINA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 230
TABLE 247 CHINA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 231
TABLE 248 CHINA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 231
TABLE 249 CHINA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 231
TABLE 250 CHINA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 232
TABLE 251 CHINA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 232
12.4.2 JAPAN 232
12.4.2.1 Growing innovation in drug research to propel market 232
TABLE 252 JAPAN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 233
TABLE 253 JAPAN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 233
TABLE 254 JAPAN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 233
TABLE 255 JAPAN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 234
TABLE 256 JAPAN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 234
TABLE 257 JAPAN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 234
TABLE 258 JAPAN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 235
TABLE 259 JAPAN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 235
12.4.3 INDIA 235
12.4.3.1 Rising research to create favorable opportunities for market players 235
TABLE 260 INDIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 236
TABLE 261 INDIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 236
TABLE 262 INDIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 236
TABLE 263 INDIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 237
TABLE 264 INDIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 237
TABLE 265 INDIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 237
TABLE 266 INDIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 238
TABLE 267 INDIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 238
12.4.4 AUSTRALIA 238
12.4.4.1 Increasing drug development initiatives to support market growth 238
TABLE 268 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 239
TABLE 269 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 239
TABLE 270 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 240
TABLE 271 AUSTRALIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 240
TABLE 272 AUSTRALIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 240
TABLE 273 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 241
TABLE 274 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 241
TABLE 275 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 242
12.4.5 SOUTH KOREA 242
12.4.5.1 Growing pharma sector to drive market 242
TABLE 276 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 243
TABLE 277 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 243
TABLE 278 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 243
TABLE 279 SOUTH KOREA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 244
TABLE 280 SOUTH KOREA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 244
TABLE 281 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 245
TABLE 282 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 245
TABLE 283 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 246
12.4.6 REST OF ASIA PACIFIC 246
TABLE 284 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 247
TABLE 285 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 247
TABLE 286 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 247
TABLE 287 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 248
TABLE 288 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 248
TABLE 289 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 248
TABLE 290 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 249
TABLE 291 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 249
12.4.7 ASIA PACIFIC: RECESSION IMPACT 249
12.5 LATIN AMERICA 250
TABLE 292 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 250
TABLE 293 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 250
TABLE 294 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 251
TABLE 295 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 251
TABLE 296 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 251
TABLE 297 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 252
TABLE 298 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 252
TABLE 299 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 252
TABLE 300 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 253
12.5.1 BRAZIL 253
12.5.1.1 Ban on animal testing of cosmetics to support market growth 253
TABLE 301 BRAZIL: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 254
TABLE 302 BRAZIL: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 254
TABLE 303 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 254
TABLE 304 BRAZIL: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 255
TABLE 305 BRAZIL: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 255
TABLE 306 BRAZIL: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 255
TABLE 307 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 256
TABLE 308 BRAZIL: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 256
12.5.2 MEXICO 256
12.5.2.1 Favorable government policies to aid market growth 256
TABLE 309 MEXICO: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 257
TABLE 310 MEXICO: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 257
TABLE 311 MEXICO: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 257
TABLE 312 MEXICO: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 258
TABLE 313 MEXICO: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 258
TABLE 314 MEXICO: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 258
TABLE 315 MEXICO: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 259
TABLE 316 MEXICO: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 259
12.5.3 REST OF LATIN AMERICA 259
TABLE 317 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 260
TABLE 318 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 260
TABLE 319 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 260
TABLE 320 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 261
TABLE 321 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 261
TABLE 322 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 262
TABLE 323 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 262
TABLE 324 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 263
12.5.4 LATIN AMERICA: RECESSION IMPACT 263
12.6 MIDDLE EAST & AFRICA 263
12.6.1 GROWING PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH 263
TABLE 325 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 264
TABLE 326 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 264
TABLE 327 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 265
TABLE 328 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 265
TABLE 329 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 265
TABLE 330 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 266
TABLE 331 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 266
TABLE 332 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 267
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 267
13 COMPETITIVE LANDSCAPE 268
13.1 INTRODUCTION 268
13.2 KEY STRATEGIES/RIGHT TO WIN 268
FIGURE 34 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORGANS-ON-CHIPS MARKET 269
13.3 REVENUE SHARE ANALYSIS 269
FIGURE 35 REVENUE SHARE ANALYSIS, 2021–2023 (USD THOUSAND) 270
13.4 MARKET SHARE ANALYSIS 270
FIGURE 36 MARKET SHARE ANALYSIS, 2023 271
TABLE 333 DEGREE OF COMPETITION: ORGANS-ON-CHIPS MARKET 271
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 272
13.5.1 STARS 272
13.5.2 EMERGING LEADERS 272
13.5.3 PERVASIVE PLAYERS 272
13.5.4 PARTICIPANTS 273
FIGURE 37 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 273
13.5.5 COMPANY FOOTPRINT 274
TABLE 334 PRODUCT & SERVICE FOOTPRINT 274
TABLE 335 REGIONAL FOOTPRINT 274
13.6 COMPANY EVALUATION MATRIX: START-UPS/SMES 275
13.6.1 PROGRESSIVE COMPANIES 275
13.6.2 RESPONSIVE COMPANIES 275
13.6.3 DYNAMIC COMPANIES 275
13.6.4 STARTING BLOCKS 275
FIGURE 38 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 276
13.6.5 COMPETITIVE BENCHMARKING 277
TABLE 336 DETAILED LIST OF KEY START-UPS/SMES IN ORGANS-ON-CHIPS MARKET 277
TABLE 337 COMPETITIVE BENCHMARKING OF START-UPS/SMES IN ORGANS-ON-CHIPS MARKET 278
13.7 COMPETITIVE SCENARIO 279
13.7.1 PRODUCT/SERVICE LAUNCHES 279
TABLE 338 ORGANS-ON-CHIPS MARKET: PRODUCT/ SERVICE LAUNCHES, 2021–2024 279
13.7.2 DEALS 279
TABLE 339 ORGANS-ON-CHIPS MARKET: DEALS, 2021–2024 279
13.7.3 OTHER KEY DEVELOPMENTS 280
TABLE 340 ORGANS-ON-CHIPS MARKET: OTHER DEVELOPMENTS, 2021–2024 280
14 COMPANY PROFILES 281
14.1 KEY PLAYERS 281
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 EMULATE, INC. 281
TABLE 341 EMULATE, INC.: COMPANY OVERVIEW 281
TABLE 342 EMULATE, INC.: PRODUCT/SERVICE LAUNCHES, 2021–2024 284
TABLE 343 EMULATE, INC.: OTHER DEVELOPMENTS, 2021–2024 285
14.1.2 MIMETAS B.V. 287
TABLE 344 MIMETAS B.V.: COMPANY OVERVIEW 287
TABLE 345 MIMETAS B.V.: DEALS, 2021–2024 288
TABLE 346 MIMETAS B.V.: OTHER DEVELOPMENTS, 2021–2024 289
14.1.3 TISSUSE GMBH 290
TABLE 347 TISSUSE GMBH: COMPANY OVERVIEW 290
TABLE 348 TISSUSE GMBH: DEALS, 2021–2024 292
TABLE 349 TISSUSE GMBH: OTHER DEVELOPMENTS, 2021–2024 292
14.1.4 CN BIO INNOVATIONS LTD. 294
TABLE 350 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW 294
TABLE 351 CN BIO INNOVATIONS LTD.: PRODUCT/SERVICE LAUNCHES, 2021–2024 296
TABLE 352 CN BIO INNOVATIONS LTD.: DEALS, 2021–2024 297
14.1.5 INSPHERO 298
TABLE 353 INSPHERO: COMPANY OVERVIEW 298
TABLE 354 INSPHERO: DEALS, 2021–2024 300
TABLE 355 INSPHERO: OTHER DEVELOPMENTS, 2021–2024 301
14.1.6 ALVEOLIX AG 302
TABLE 356 ALVEOLIX AG: COMPANY OVERVIEW 302
TABLE 357 ALVEOLIX AG: PRODUCT LAUNCHES, 2021–2024 303
TABLE 358 ALVEOLIX AG: DEALS, 2021–2024 303
14.1.7 FLUIGENT 304
TABLE 359 FLUIGENT: COMPANY OVERVIEW 304
TABLE 360 FLUIGENT: PRODUCT/SERVICE LAUNCHES, 2021–2024 306
14.1.8 NORTIS, INC. 307
TABLE 361 NORTIS, INC.: COMPANY OVERVIEW 307
14.1.9 HESPEROS, INC. 308
TABLE 362 HESPEROS, INC.: COMPANY OVERVIEW 308
TABLE 363 HESPEROS, INC.: OTHER DEVELOPMENTS, 2021–2024 310
14.1.10 AXOSIM 311
TABLE 364 AXOSIM: COMPANY OVERVIEW 311
TABLE 365 AXOSIM: PRODUCT LAUNCHES, 2021–2024 312
TABLE 366 AXOSIM: DEALS, 2021–2024 312
14.1.11 BEONCHIP 313
TABLE 367 BEONCHIP: COMPANY OVERVIEW 313
14.1.12 ALTIS BIOSYSTEMS 314
TABLE 368 ALTIS BIOSYSTEMS: COMPANY OVERVIEW 314
TABLE 369 ALTIS BIOSYSTEMS: PRODUCT/SERVICE LAUNCHES, 2021–2024 315
TABLE 370 ALTIS BIOSYSTEMS: DEALS, 2021–2024 315
14.1.13 SYNVIVO, INC. 316
TABLE 371 SYNVIVO, INC.: COMPANY OVERVIEW 316
14.1.14 OBATALA SCIENCES 318
TABLE 372 OBATALA SCIENCES: COMPANY OVERVIEW 318
14.1.15 DYNAMIC42 GMBH 320
TABLE 373 DYNAMIC42 GMBH: COMPANY OVERVIEW 320
TABLE 374 DYNAMIC42 GMBH: PRODUCT LAUNCHES, 2021–2024 321
TABLE 375 DYNAMIC42 GMBH: DEALS, 2021–2024 321
TABLE 376 DYNAMIC42 GMBH: OTHER DEVELOPMENTS, 2021–2024 322
14.1.16 LENA BIOSCIENCES 323
TABLE 377 LENA BIOSCIENCES: COMPANY OVERVIEW 323
TABLE 378 LENA BIOSCIENCES: OTHER DEVELOPMENTS, 2021–2024 325
14.1.17 AIM BIOTECH PTE. LTD. 326
TABLE 379 AIM BIOTECH PTE. LTD.: COMPANY OVERVIEW 326
TABLE 380 AIM BIOTECH PTE. LTD.: PRODUCT/SERVICES LAUNCHES, 2021–2024 327
TABLE 381 AIM BIOTECH PTE. LTD.: DEALS, 2021–2024 327
14.1.18 REACT4LIFE 328
TABLE 382 REACT4LIFE: COMPANY OVERVIEW 328
14.1.19 INITIO CELL 330
TABLE 383 INITIO CELL: COMPANY OVERVIEW 330
14.1.20 NETRI SAS 331
TABLE 384 NETRI SAS: COMPANY OVERVIEW 331
TABLE 385 NETRI SAS: PRODUCT LAUNCHES, 2021–2024 332
TABLE 386 NETRI SAS: DEALS, 2021–2024 333
TABLE 387 NETRI SAS: OTHER DEVELOPMENTS, 2021–2024 333
14.1.21 REVIVOCELL 334
TABLE 388 REVIVOCELL: COMPANY OVERVIEW 334
14.1.22 BI/OND 336
TABLE 389 BI/OND: COMPANY OVERVIEW 336
TABLE 390 BI/OND: OTHER DEVELOPMENTS, 2021–2024 337
14.1.23 BIOMIMX S.R.L. 338
TABLE 391 BIOMIMX S.R.L.: COMPANY OVERVIEW 338
14.1.24 CHERRY BIOTECH 340
TABLE 392 CHERRY BIOTECH: COMPANY OVERVIEW 340
14.1.25 ELVESYS 341
TABLE 393 ELVESYS: COMPANY OVERVIEW 341
14.1.26 JAVELIN BIOTECH 342
TABLE 394 JAVELIN BIOTECH: COMPANY OVERVIEW 342
TABLE 395 JAVELIN BIOTECH: DEALS, 2021–2024 343
14.1.27 KIRKSTALL LTD. 344
TABLE 396 KIRKSTALL LTD.: COMPANY OVERVIEW 344
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 345
15.1 DISCUSSION GUIDE 345
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 349
15.3 CUSTOMIZATION OPTIONS 351
15.4 RELATED REPORTS 351
15.5 AUTHOR DETAILS 352